Moskowitz J, Fain J N
J Clin Invest. 1969 Oct;48(10):1802-8. doi: 10.1172/JCI106146.
Prostaglandin E(1) (PGE(1)) at a concentration of 1 ng/ml antagonized theophylline, and norepinephrine induced release of glycerol and free fatty acids (FFA) in human fat cell preparations. Insulin at higher doses also inhibited theophylline-stimulated lipolysis. The N(6)-2-0'dibutyryl derivative of cyclic adenosine monophosphate (DCAMP) stimulated lipolysis. Prostaglandin E(1) did not significantly inhibit the lipid mobilizing effects of DCAMP. Changes in glycogen phosphorylase activity after treatment with theophylline, norepinephrine, DCAMP, and PGE(1) paralleled those of lipolysis. These results suggest that in man as in experimental animals lipolysis and phosphorylase activity are regulated through processes involving cyclic AMP and that PGE(1) appears to exert its antilipolytic effect in human fat cells, as in rat fat cells, by interfering at the level of adenyl cyclase with the accumulation of cyclic AMP.
浓度为1纳克/毫升的前列腺素E(1)(PGE(1))可拮抗茶碱,去甲肾上腺素可诱导人脂肪细胞制剂中甘油和游离脂肪酸(FFA)的释放。高剂量胰岛素也可抑制茶碱刺激的脂肪分解。环磷酸腺苷(DCAMP)的N(6)-2-0'二丁酰衍生物可刺激脂肪分解。前列腺素E(1)并未显著抑制DCAMP的脂质动员作用。用茶碱、去甲肾上腺素、DCAMP和PGE(1)处理后糖原磷酸化酶活性的变化与脂肪分解的变化平行。这些结果表明,在人类和实验动物中,脂肪分解和磷酸化酶活性是通过涉及环磷酸腺苷的过程来调节的,并且PGE(1)似乎在人脂肪细胞中,如同在大鼠脂肪细胞中一样,通过在腺苷酸环化酶水平干扰环磷酸腺苷的积累来发挥其抗脂解作用。